Monthly Archives: June 2019

Sunpharma deals with China

sun pharma news

Sun Pharma and China Medical System Holdings engage into a License Agreement for Tildrakizumab in Greater China. This deal gives Sun Pharma grants to Greater China market for Tildrakizumab. China to become a valuable market in future as  currently 5 million suffering from psoriasis and psoriatic arthritis . Tildrakizumab enjoys patents in China

 

Sources: Bseindia.com